(Q45026144)

8 December 2017

title

Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome (English)

1 reference

8 December 2017

1 reference

1 reference

1 reference

1 reference

acute myeloid leukemia

1 reference

Sekeres MA

1

1 reference

8 December 2017

Stone RM

2

1 reference

8 December 2017

Zahrieh D

3

1 reference

8 December 2017

Neuberg D

4

1 reference

8 December 2017

Morrison V

5

1 reference

8 December 2017

De Angelo DJ

6

1 reference

8 December 2017

Galinsky I

7

1 reference

8 December 2017

Lee SJ

8

1 reference

8 December 2017

publication date

1 April 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

18

1 reference

8 December 2017

issue

4

1 reference

8 December 2017

page(s)

809-816

1 reference

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Management of acute myeloid leukemia in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

9/Geriatric Depression Scale (GDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

The reliability and validity of the Geriatric Depression Rating Scale administered by telephone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Do patients want to participate in medical decision making?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Screening the elderly. A brief instrumental activities of daily living measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Feasibility and effects of decision aids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Collusion in doctor-patient communication about imminent death: an ethnographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Tailoring the treatment of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Myelodysplastic syndromes: a study of 101 cases according to the FAB classification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Discrepancies between patient and physician estimates for the success of stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Risk communication in clinical practice: putting cancer in context.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403289

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403289

1 reference

Dimensions Publication ID

8 December 2017

1043374573

0 references

1 reference